£40 OFF First Order
£25 OFF Every Order
Free BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.
Two of the most common UK semaglutide treatments at a glance. Your prescriber confirms which is suitable for you during your consultation.
Semaglutide · Weekly injection
Oral Semaglutide · Daily tablet
Moving from a weekly injection to the daily tablet isn’t a like-for-like swap. Your prescriber matches your current dose to the right tablet dose — here’s the guide they work from.
Pick your current weekly dose
Start on 1.5mg — about 3 more phases (roughly 90 days) to the 25mg target dose. You restart titration at the first tablet phase. Always follow your prescriber’s instructions when switching medication.
Wegovy® Pill — Daily prescription tablet for eligible adults. Prescribed and reviewed by UK-registered clinicians. No subscriptions • Transparent pricing.
Meet the once-daily Wegovy® tablet, the new Wegovy pill in pill form, containing semaglutide, the same active ingredient used in Wegovy injections. It offers a needle-free treatment option for eligible adults who may prefer a daily tablet as part of their medically supervised weight management plan. Semaglutide works to regulate appetite, and some people notice appetite changes within a few weeks. Wegovy tablets are prescription-only medicines and can only be supplied after a clinical assessment by a UK-registered prescriber. This weight loss medication is not available over the counter. There are currently no confirmed NHS prescribing guidelines for the tablet for weight management.
Evidence behind Wegovy® Pill: clinical studies have evaluated once-daily oral semaglutide in adults living with obesity, or overweight with weight-related health conditions. When used alongside a reduced-calorie diet and increased physical activity, participants taking Wegovy® Pill achieved greater average weight reduction than those receiving placebo over 64 weeks. Individual outcomes varied depending on factors such as treatment adherence and lifestyle changes. The medicine should always be used as part of a medically supervised weight management plan, rather than as a standalone treatment.
For many people, managing their weight is not simply about eating less or exercising more. Hunger, cravings and feeling satisfied after meals can all play a role, making long-term weight management more challenging. Wegovy® Pill is a prescription-only medicine that contains semaglutide, an active ingredient that helps support weight management in eligible adults. It works by mimicking the action of a naturally occurring hormone involved in appetite regulation, helping some people feel fuller, stay satisfied for longer and experience fewer food cravings. When combined with a reduced-calorie diet and increased physical activity, this may help support healthier eating habits as part of a structured weight management plan. It is important to understand that Wegovy® is not a quick fix or a replacement for healthy lifestyle choices. It is designed to support long-term weight management under the guidance of a qualified healthcare professional. Individual responses to treatment vary, and regular follow-up appointments help ensure that the treatment continues to be suitable for your needs. The once-daily Wegovy® tablet is now available through selected private healthcare providers and pharmacies in the UK following approval by the Medicines and Healthcare products Regulatory Agency (MHRA). It is prescribed only after a clinical assessment to determine whether it is appropriate for you. At the time of writing, it is not routinely available on the NHS for weight management.
Switching from a weekly injection to a daily tablet is not a direct dose-for-dose change. Although both medicines contain semaglutide, the way they are absorbed by the body is different. Your prescriber will review your current treatment, medical history and weight management plan before deciding whether switching is appropriate and which tablet strength to prescribe.
For some people, taking a tablet for weight management each morning may fit more naturally into their lifestyle than giving a weekly injection, especially for eligible adults who prefer not to use injections. Potential reasons why a daily tablet may be preferred include: a daily tablet can help eligible adults lose weight as part of a medically supervised plan; it contains the same active ingredient as Wegovy injections; it is taken once daily as part of a regular routine; it is suitable for adults who meet prescribing criteria following clinical assessment; and it is prescribed and monitored by UK-registered healthcare professionals. The tablet does require specific instructions for taking Wegovy pills correctly. It should be taken in the morning on an empty stomach with a small amount of plain water, and you should wait at least 30 minutes before eating, drinking or taking other medicines.
Wegovy® Pill is a prescription-only medicine (POM) containing semaglutide, a GLP-1 receptor agonist used to support long-term weight management in eligible adults. It has been approved in the UK as the first oral GLP-1 medicine licensed specifically for weight management, offering an alternative for people who may prefer a daily tablet instead of a weekly injection. Treatment should always be combined with a reduced-calorie diet, increased physical activity and ongoing lifestyle changes. The medicine is intended to support a wider weight management programme rather than replace healthy habits. As with all prescription medicines, Wegovy may not be suitable for everyone. A qualified healthcare professional will assess your medical history, current medicines and individual health needs before deciding whether treatment is appropriate.
Semaglutide in Wegovy® Pill acts like a natural hormone involved in hunger signals and digestion. In simple terms, semaglutide helps regulate appetite so you feel satisfied sooner and for longer. As a result, some people taking Wegovy® may feel fuller after meals, feel less hungry between meals, experience fewer food cravings, and find it easier to manage portion sizes. This effect can also slow digestion by delaying stomach emptying, which may help fullness last longer. These effects may help reduce overall calorie intake when Wegovy® is used alongside a reduced-calorie diet and increased physical activity. Wegovy® does not increase metabolism or burn fat directly. Instead, it supports appetite regulation as part of a medically supervised weight management programme. Individual responses to treatment vary, and not everyone will experience the same effects.
Following a clinical assessment, Wegovy Pill may be considered for adults who meet the licensed prescribing criteria. This generally includes adults who have a Body Mass Index (BMI) of 30 kg/m² or above (obesity), or a BMI of 27 kg/m² or above together with at least one weight-related health condition, such as high blood pressure, high cholesterol, obstructive sleep apnoea, cardiovascular disease, prediabetes or other appropriate weight-related conditions. Eligibility is determined by a healthcare professional. Meeting BMI criteria alone does not automatically mean the medicine is suitable. Your prescriber will also consider factors such as your medical history, current medicines, previous weight management approaches and whether the benefits and risks of treatment are appropriate for you.
Wegovy may not be suitable for everyone and is not recommended for people who are under 18 years of age, are pregnant or planning a pregnancy, are breastfeeding, have an allergy to semaglutide or any of the medicine's ingredients, or have certain medical conditions where treatment may not be appropriate. Always tell your clinician about any existing medical conditions or medicines you are taking before starting treatment.
Wegovy Pill may offer several potential benefits when prescribed appropriately and used alongside lifestyle changes, such as a needle-free alternative to weekly injections, once-daily oral dosing, the same active ingredient as Wegovy injections, support for appetite regulation, the ability to be prescribed remotely following an online clinical consultation when seeking a Wegovy pill online, and suitability for eligible adults who prefer tablets to injections. These are potential benefits observed during treatment and should not be interpreted as guaranteed outcomes. Individual experiences vary with any weight loss treatment.
Approval of Wegovy Pill was supported by clinical research involving adults living with obesity, or overweight with weight-related medical conditions. In one major clinical trial, participants took oral semaglutide once daily alongside a reduced-calorie diet, increased physical activity and ongoing lifestyle support. After 64 weeks, participants taking oral semaglutide achieved an average body weight reduction of approximately 14% to 17%, depending on treatment adherence, while those receiving placebo experienced substantially smaller average reductions. Individual outcomes varied between participants. Clinical trials also found that many participants achieved a reduction of at least 5% of their starting body weight, although not everyone responded in the same way. These findings helped support MHRA approval of Wegovy Pill for weight management in eligible adults.
Although Wegovy can support weight management, it is not intended to replace healthy lifestyle habits. The medicine works best when combined with a nutritionally balanced, reduced-calorie diet, regular physical activity, good sleep habits, long-term behaviour changes, and ongoing support from healthcare professionals where appropriate. Making sustainable lifestyle changes remains an important part of long-term weight management. For some people, stopping treatment may lead to weight regain over time. Your healthcare professional can discuss longer-term management options based on your individual circumstances.
Weight management is different for everyone. Factors that can influence treatment outcomes include starting body weight, medical history, existing health conditions, physical activity levels, dietary habits, treatment adherence, and individual response to semaglutide. Some people may experience meaningful weight reduction, while others may achieve smaller changes. Regular follow-up appointments allow your prescriber to review progress, discuss any side effects and decide whether continuing treatment remains appropriate.
Because Wegovy is a prescription-only medicine, it cannot be supplied without an assessment by a qualified healthcare professional. This helps ensure taking Wegovy pills safely requires a clinical review rather than self-selection. During your online consultation, your clinician may review your height and weight, BMI, medical history, current medicines, previous weight loss tablets or injections where relevant, existing health conditions, and whether Wegovy is a suitable treatment option for you. If prescribed, you will also receive guidance on how to take the medicine correctly, what side effects to look out for and when to seek medical advice.
Wegovy® Pill should always be taken exactly as prescribed by your healthcare professional. Following the correct instructions is important because the tablet is absorbed differently from many other medicines. Taking it incorrectly may reduce how much of the medicine your body absorbs.
Take your tablet once daily, usually first thing in the morning on an empty stomach, with no more than 120 ml of plain water. Swallow the tablet whole without crushing, splitting or chewing it, and wait at least 30 minutes before eating, drinking anything other than water, or taking any other medicines. Taking the tablet in the same way each day can help establish a routine and support consistent treatment. If you miss a dose, do not take a double dose later the same day. Always follow the instructions provided by your prescriber and the Patient Information Leaflet.
Treatment usually begins with the lowest available dose to help your body adjust to Wegovy® Pill and reduce the likelihood of stomach-related side effects, such as nausea or vomiting. Your clinician will advise when to increase your dose. In most cases, Wegovy® Pill is introduced gradually over several months, allowing your body time to adapt before moving to the next strength. The exact dosing schedule may vary depending on how well you tolerate treatment.
Your clinician may adjust the schedule depending on how well you tolerate treatment, with increases made monthly from the lowest dose up to the maximum dose where appropriate. Do not increase your dose yourself without medical advice.
If you forget to take your tablet, skip the missed dose and take your next scheduled dose the following day. Do not take two tablets on the same day to make up for a missed dose. If you miss several doses, speak with your healthcare provider before restarting treatment, as you may need further advice.
If you are already using Wegovy injections, your treatment may be reviewed if you wish to move to the daily tablet. Although both medicines contain semaglutide, they are absorbed differently and are not interchangeable on a milligram-for-milligram basis. Your clinician will consider your current injection dose, how long you have been receiving treatment, any side effects experienced, your overall treatment goals, and your medical history. Patients should not switch between products without guidance from a qualified healthcare professional. Neither option is considered universally better. The most suitable treatment depends on your health, preferences and medical assessment.
Like all medicines, Wegovy can cause side effects, although not everyone experiences them, and some Wegovy pill side effects may need urgent medical help. Most side effects are mild to moderate and usually improve within a few weeks as your body adjusts to treatment.
These may affect more than 1 in 10 people: nausea, vomiting, diarrhoea, and constipation. These are the most frequently reported side effects during treatment and often occur during dose increases.
Some people may also experience stomach pain, indigestion, heartburn, bloating, headache, tiredness, dizziness, reduced appetite, burping and wind. If you take diabetes medicine, be alert to changes in blood sugar and speak with your clinician if you are worried about symptoms. If symptoms become troublesome or do not improve, speak with your healthcare professional.
Although uncommon, seek urgent medical advice if you experience symptoms that may suggest a serious reaction, including severe or persistent abdominal pain that may spread to your back (which could indicate acute pancreatitis); signs of a severe allergic reaction, such as swelling of the face, lips, tongue or throat, difficulty breathing, or a widespread rash; persistent vomiting leading to dehydration; symptoms of gallbladder problems, such as severe pain in the upper abdomen, fever or yellowing of the skin or eyes; severe stomach pain that is persistent or getting worse, especially with nausea or vomiting; warning signs of low blood sugar, particularly if you also use diabetes medicines, such as sweating, shakiness, confusion or feeling faint; symptoms of low blood pressure, such as dizziness or lightheadedness when standing up; and symptoms of kidney or bladder stones, including back or lower abdominal pain, difficulty urinating, or changes in urine colour. Wegovy is also associated with serious risks such as pancreatitis and thyroid tumours based on animal studies, so discuss any relevant personal or family history with a clinician. Stop taking the medicine and seek immediate medical attention if you think you are having a serious allergic reaction.
Before starting Wegovy, tell your healthcare professional if you have kidney problems, liver disease, problems with your pancreas, gallbladder disease or gallstones, diabetic eye disease (diabetic retinopathy), severe stomach or digestive disorders, are taking medicines for diabetes (particularly insulin or sulphonylureas), or have any other significant medical conditions. Your clinician will determine whether Wegovy is appropriate for you.
Wegovy® should not be used during pregnancy or while breastfeeding. If you are pregnant, think you may be pregnant, planning a pregnancy, or become pregnant while taking Wegovy®, speak to your healthcare professional as soon as possible. They will advise whether you should stop treatment and discuss suitable alternatives. If you use the contraceptive pill or oral contraceptive pill, speak to your prescriber about whether vomiting or diarrhoea during treatment could affect reliability and whether extra protection is advised. If you're breastfeeding or planning to breastfeed, speak to your healthcare professional before starting Wegovy®.
Tell your prescriber about all medicines, including over the counter medicines, vitamins and herbal supplements you take. Some medicines may affect, or be affected by, Wegovy treatment. This is particularly important if you take medicines for diabetes, high blood pressure, thyroid conditions, blood thinning medicines, or medicines that require careful absorption. Do not start or stop medicines without discussing them with your healthcare professional.
There are no specific restrictions on alcohol within the prescribing information. However, excessive alcohol intake may increase the risk of certain side effects, including dehydration and gastrointestinal symptoms. Maintaining a balanced diet, staying hydrated and engaging in regular physical activity remain important parts of your treatment plan.
Regular reviews with your prescriber help ensure treatment remains safe and appropriate. During follow-up appointments, your clinician may assess weight changes, tolerance of the medicine, side effects, lifestyle progress, whether dose adjustments are needed, and whether continuing treatment remains appropriate. These reviews provide an opportunity to ask questions and discuss any concerns about your treatment.
Wegovy® is a Prescription Only Medicine (POM). It should only be used following assessment by a qualified healthcare professional and alongside a reduced-calorie diet and increased physical activity. Individual responses to treatment vary. Do not share your medicine with anyone else. Always read the Patient Information Leaflet before starting treatment. Seek medical advice promptly if you experience severe or unexpected side effects. Keep all medicines out of the sight and reach of children.
Maintaining a healthy weight can have a positive impact on overall health for many people. For individuals living with obesity or overweight and related health conditions, even modest weight loss may contribute to improvements in general wellbeing when achieved through a combination of medical treatment and lifestyle changes. Weight management may support improved mobility and physical function, reduced strain on joints, better management of some weight-related health conditions, improved energy levels for daily activities, better sleep quality for some individuals, and increased confidence in maintaining healthy lifestyle habits. These outcomes vary from person to person and depend on many factors, including overall health, lifestyle and adherence to treatment. Wegovy® should be viewed as one part of a wider weight management plan rather than a standalone solution.
There is no single weight management treatment that suits everyone. Your healthcare professional will recommend the option they believe is most appropriate following your consultation, as there are different other weight loss tablets and injectable options, and suitability depends on your individual needs and medical history. Alternative approaches may include:
Contains the same active ingredient (semaglutide) but is administered once weekly by injection. Some people prefer this option as it does not require a daily routine.
For some people, dietary advice, increased physical activity and behavioural support may be appropriate before considering prescription medicines.
Depending on your medical history, BMI and existing health conditions, your clinician may discuss other weight loss tablets where clinically appropriate, or refer you for specialist weight management services where appropriate. Treatment recommendations are always made on an individual basis following a clinical assessment.
Wegovy® Pill is now available through selected private clinics and UK pharmacies following approval by the Medicines and Healthcare products Regulatory Agency (MHRA). The National Institute for Health and Care Excellence (NICE) is expected to assess the medicine separately to determine whether it should be recommended for NHS use. This process includes reviewing clinical evidence, cost effectiveness and wider healthcare considerations. Availability through NHS services may change in the future as guidance is updated.
Both contain the active ingredient semaglutide, but they're taken differently. Wegovy® Pill is taken once a day, while Wegovy® injections are taken once a week. Your clinician will help you decide which option is more suitable for you.
Yes. Wegovy® Pill is a Prescription Only Medicine (POM) and is not sold over the counter. It can only be supplied after assessment by a qualified healthcare professional.
There's no fixed treatment length. Your clinician will review your progress regularly and discuss whether continuing treatment is right for you.
Yes. Wegovy® works best when it's used alongside a reduced-calorie diet and regular physical activity. It's designed to support your weight management plan, not replace healthy habits.
Simply skip the missed dose and take your next tablet at your usual time the following day. Don't take a double dose to make up for a missed dose.
If you're thinking about stopping treatment, it's best to speak with your healthcare professional first. They can advise you on the safest way to do so and discuss your next steps.
For many people, yes. If you'd rather avoid weekly injections, the daily tablet may be a suitable option. Your clinician will assess whether it's appropriate for your individual needs.
There are no specific restrictions in the prescribing information. However, alcohol may worsen stomach-related side effects for some people, so moderation is generally advisable.
Everyone responds differently. Some people notice changes sooner than others, while for some it may take longer. Your clinician will review your progress during follow-up appointments.
Some people with diabetes may be prescribed semaglutide, but suitability depends on individual circumstances and any other medicines being taken. Your clinician will advise you.
No. Wegovy should not be used during pregnancy and is not recommended while breastfeeding.
Wegovy Pill is currently available through private healthcare providers following a clinical assessment. NHS availability may change in the future as guidance develops.
If you are considering prescription weight management treatment, the first step is to complete our secure online consultation. A UK-registered healthcare professional will review your health information, assess whether Wegovy® Pill is suitable for you and discuss the most appropriate treatment options, or recommend another weight loss treatment if it is not suitable. If treatment is not considered suitable, your clinician may recommend an alternative approach based on your individual circumstances. Start your online consultation today and take the first step towards a medically supervised weight management plan.
Disclaimer: Wegovy® (semaglutide) is a Prescription Only Medicine (POM). Treatment is subject to a clinical assessment by a UK-registered prescriber. All medicines carry benefits and risks. Always read the Patient Information Leaflet before use. Individual results vary.
Your prescriber sets a starting dose and plan for you. The early days focus on settling in.
Cravings ease off, and eating well starts to feel less like a fight.
You'll feel it before the scales show it — more energy, a bit more like yourself.
Some weeks are harder than others. Your care team keeps you on track.
Now it's about holding on to what you've built. No rush, no pressure.
Your whole journey in one app — how, simply, all in one pocket.
Achieve your goals in just a few simple steps.
Select safe UK treatments. Quick answers.
Our expert team will use your consultation as the basis of our recommendation and communicate with you.
We'll deliver direct to you, as quickly as tomorrow.
Short videos from patients about the care behind the service.
